Osteoporosis Management

Diagnostic Testing

Bone mineral density (BMD) testing with vertebral fracture assessment or spinal x-ray should be performed every 1-2 years during treatment, as recommended by the American College of Rheumatology 1

Bisphosphonates, such as alendronate, are commonly used for the treatment and prevention of osteoporosis, with the American College of Physicians and the Infectious Diseases Society of America providing guidelines for their use 2, 3, 4
The recommended dose of alendronate for osteoporosis treatment is 70 mg once weekly (preferred) or 10 mg daily for postmenopausal women and men, and 35 mg once weekly or 5 mg daily for prevention, as recommended by the American College of Physicians 2, 3, 5, 6
Patients should take alendronate on an empty stomach after an overnight fast, with a full glass of plain water, and remain upright for at least 30 minutes after taking, to ensure optimal absorption and minimize adverse effects 2, 6, 7

Alendronate is contraindicated in patients with severe renal impairment (creatinine clearance <35 mL/min), hypocalcemia, esophageal abnormalities, inability to stand/sit upright for at least 30 minutes, or hypersensitivity to any component of the product, as stated by the American College of Physicians and the Infectious Diseases Society of America 8, 4, 2, 3, 6
The American Gastroenterological Association advises against taking alendronate in patients with cirrhosis who may have portal hypertension and esophageal varices due to potential risk of precipitating variceal hemorrhage, and suggests risedronate as a safer alternative if esophageal varices are a concern 9

Patients should receive adequate supplementation alongside alendronate, including calcium (1000-1200 mg daily) and vitamin D (600-800 IU daily), as recommended by the American College of Physicians and the Infectious Diseases Society of America 2, 3, 6, 7, 4
Routine bone mineral density (BMD) monitoring is not recommended during the initial 5-year treatment period, but measuring 25(OH)D levels may be considered to ensure adequate vitamin D status, as suggested by the Infectious Diseases Society of America and the American College of Physicians 2, 3, 4

Common adverse effects of alendronate include upper GI symptoms (abdominal pain, dyspepsia, acid regurgitation) and musculoskeletal pain, while rare but serious adverse effects include osteonecrosis of the jaw and atypical femoral fractures, as reported by the American College of Physicians and the Infectious Diseases Society of America 2, 3, 6, 4
Alendronate demonstrates significant efficacy in reducing vertebral fractures by 47-56%, hip fractures by approximately 50%, and all clinical fractures by approximately 30%, as reported by the American College of Physicians 2, 3, 5

The European Society for Medical Oncology suggests that premenopausal women on ovarian suppression may benefit from bisphosphonate therapy, such as alendronate, and the American College of Rheumatology recommends alendronate for the treatment of glucocorticoid-induced osteoporosis in both men and women receiving glucocorticoids equivalent to ≥7.5 mg prednisone daily, although the evidence is lower quality 10, 11, 3
The optimal duration of therapy is typically 5 years, after which continuation should be reassessed, and patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use, as noted in the FDA-approved label and recommended by the American College of Physicians 2, 3, 6, 7